[VRTX] YoY Quarter Result on 30-Sep-2023 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
07-Nov-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 13.06%
YoY- 11.26%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
Revenue 2,771,900 2,483,500 2,334,300 1,984,164 1,538,271 949,828 784,535 23.38%
PBT 1,224,100 1,179,200 1,176,400 1,082,741 745,871 70,666 136,511 44.08%
Tax 178,700 143,900 245,900 230,813 78,437 13,148 8,055 67.54%
NP 1,045,400 1,035,300 930,500 851,928 667,434 57,518 128,746 41.72%
Tax Rate -14.60% -12.20% -20.90% -21.32% -10.52% -18.61% -5.90% -
Total Cost 1,726,500 1,448,200 1,403,800 1,132,236 870,837 892,310 655,789 17.49%
Ratio Analysis
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
NP Margin 37.71 41.69 39.86 42.94 43.39 6.06 16.41 14.86%
Per Share
30/09/24 30/09/23 30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 CAGR
EPS 4.05 4.01 3.63 3.30 2.56 0.22 0.51 41.20%
EPS Diluted 4.01 3.97 3.59 3.28 2.53 0.22 0.50 41.43%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.